I'm also disappointed in the lack of news flow for the burns study. The market for topical may be smaller, but it should have been the fastest/easiest to get to market.
A topical product in the market could be massive, easily cash flowing all R&D for other products/indications plus profit.
Also, feeling a bit uncertain about the pure sepsis opportunity given the low peak serum concentrations. Compare them to the MICs of various bugs in the pre-clinical slides.
I'm also disappointed in the lack of news flow for the...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
-0.013(3.23%) |
Mkt cap ! $109.8M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 37.5¢ | $26.59K | 70.05K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 8865 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 33 | 1 |
View Market Depth
| Last trade - 11.12am 01/08/2025 (20 minute delay) ? |
| RCE (ASX) Chart |